Hong Kong’s Centre for Immunology & Infection combines precision medicine and public health
The Institut Pasteur and the University of Hong Kong have built the Centre for Immunology & Infection, C2i. This interdisciplinary research center is the continuation of a 20-year partnership established with HKU on the HKU-Pasteur Research Pole (HKU-PRP). Housed within the Hong Kong Science and Technology Park, its ambition is to advance medical innovation to meet future public health challenges. Its activities are structured into four major research programs, including the development of new vaccine platforms against influenza viruses based on the expertise acquired by the HKU-PRP in this field, and the Healthy Human Global Project based on the success of the Institut Pasteur's Milieu Intérieur project.